We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.2B
AUM Growth
+$921M
Cap. Flow
+$201M
Cap. Flow %
1.79%
Top 10 Hldgs %
19.59%
Holding
393
New
24
Increased
178
Reduced
115
Closed
8

Top Sells

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$52.2M
2
BRKR icon
Bruker
BRKR
+$42.9M
3
WSM icon
Williams-Sonoma
WSM
+$40.5M
4
MMM icon
3M
MMM
+$34.1M
5
SBNY
Signature Bank
SBNY
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 16.42%
3 Healthcare 14.76%
4 Industrials 14.05%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDK
101
DELISTED
CDK Global, Inc.
CDK
$40.9M 0.36%
822,418
+16,192
+2% +$857K
SBNY
102
DELISTED
Signature Bank
SBNY
$40.2M 0.36%
163,779
-114,098
-41% -$27.7M
INTC icon
103
Intel
INTC
$427B
$40.2M 0.36%
715,940
+26,939
+4% +$1.58M
SJM icon
104
J.M. Smucker
SJM
$13.5B
$40M 0.36%
308,684
+23,512
+8% +$3.12M
POWI icon
105
Power Integrations
POWI
$3.22B
$39.9M 0.35%
485,618
-15,836
-3% -$1.28M
CINF icon
106
Cincinnati Financial
CINF
$27.6B
$38.5M 0.34%
330,536
-65,525
-17% -$7.56M
IDA icon
107
Idacorp
IDA
$8.08B
$38.1M 0.34%
391,165
+1,995
+0.5% +$200K
CTXS
108
DELISTED
Citrix Systems Inc
CTXS
$38M 0.34%
323,969
+29,679
+10% +$3.7M
WTS icon
109
Watts Water Technologies
WTS
$11.3B
$37.6M 0.33%
257,858
-9,589
-4% -$1.27M
GMED icon
110
Globus Medical
GMED
$11B
$37.2M 0.33%
480,214
-20,009
-4% -$1.42M
SLGN icon
111
Silgan Holdings
SLGN
$4.49B
$37.1M 0.33%
894,716
+120,394
+16% +$5.11M
LSTR icon
112
Landstar System
LSTR
$6.02B
$37M 0.33%
234,393
-9,329
-4% -$1.57M
SIGI icon
113
Selective Insurance
SIGI
$5.7B
$36.3M 0.32%
447,127
+128,078
+40% +$9.79M
ISRG icon
114
Intuitive Surgical
ISRG
$127B
$35.8M 0.32%
116,856
+3,672
+3% +$1.03M
AOS icon
115
A.O. Smith
AOS
$8.59B
$35.8M 0.32%
496,230
+11,526
+2% +$795K
TDC icon
116
Teradata
TDC
$2.89B
$35.4M 0.31%
708,513
-20,828
-3% -$948K
PG icon
117
Procter & Gamble
PG
$338B
$34.4M 0.31%
255,128
-18,088
-7% -$2.45M
TSCO icon
118
Tractor Supply
TSCO
$16.4B
$33.8M 0.3%
908,535
+55,165
+6% +$2.02M
MTX icon
119
Minerals Technologies
MTX
$2.3B
$33.4M 0.3%
425,061
+67,072
+19% +$5.42M
WSM icon
120
Williams-Sonoma
WSM
$27.5B
$33M 0.29%
413,692
-475,812
-53% -$40.5M
FFIV icon
121
F5
FFIV
$22.5B
$33M 0.29%
176,607
+9,973
+6% +$1.92M
SXT icon
122
Sensient Technologies
SXT
$5.25B
$32.3M 0.29%
372,664
-16,103
-4% -$1.36M
CMI icon
123
Cummins
CMI
$84.8B
$32.2M 0.29%
132,255
-844
-0.6% -$216K
CSGS
124
DELISTED
CSG Systems International
CSGS
$32M 0.28%
679,123
-25,503
-4% -$1.16M
MAS icon
125
Masco
MAS
$14.8B
$31.9M 0.28%
541,043
+212,512
+65% +$13.1M

Similar funds

Boston Trust Walden's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Trust Walden held 393 positions worth $11.2B, up 8.9% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2021 filing shows 24 new, 178 increased, 115 reduced and 8 closed positions. Its largest new stake was Helen of Troy: 132,720 shares worth $30.3M. The largest sale was Cantel Medical Corporation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2021 buy was Helen of Troy: 132,720 shares worth $30.3M.
  • Boston Trust Walden added most to Chemed in Q2 2021, an estimated $33.2M increase.
  • Boston Trust Walden's biggest Q2 2021 reduction was Bruker, cutting an estimated $42.9M.
  • Boston Trust Walden fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $52.2M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $11.2B portfolio in Q2 2021.
  • Boston Trust Walden opened 24 new positions and closed 8 in Q2 2021.
  • Boston Trust Walden's portfolio value rose 8.9% quarter-over-quarter to $11.2B.

Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.